Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Orvosi Hetilap|June 27, 2013
[Kidney function and liver transplantation]György Gámán, Fanni Gelley, Zsuzsa Gerlei, et al.
Orvosi Hetilap|February 27, 2018
[Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017]Béla Hunyady, Zsuzsanna Gerlei, Judit Gervain, et al.
Orvosi Hetilap|February 21, 2017
[Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 15 October 2016]Béla Hunyady, Zsuzsanna Gerlei, Judit Gervain, et al.
Gerontology|October 1, 2010
Increased total scavenger capacity and decreased liver fat content in rats fed dehydroepiandrosterone and its sulphate on a high-fat dietZoltan Magyar, Gabor Bekesi, Karoly Racz, et al.
Orvosi Hetilap|June 19, 2010
[New-onset diabetes mellitus and liver transplantation, with special consideration of recurrent hepatitis C]Balázs Nemes, Fanni Gelley, Gergely Zádori, et al.
Orvosi Hetilap|July 3, 2013
[Hepatitis C virus recurrence after liver transplantation in Hungary. Trends over the past 10 years]Fanni Gelley, György Gámán, Zsuzsanna Gerlei, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trialsPatrick Marcellin, Hugo Cheinquer, Manuela Curescu, et al.
Orvosi Hetilap|October 13, 2007
[The recurrence of hepatitis C virus after liver transplantation]Balázs Nemes, Eniko Sárváry, Zsuzsa Gerlei, et al.
BMC Research Notes|January 9, 2014
IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohortAlajos Pár, Gabriella Pár, István Tornai, et al.
Clinical and Experimental Hepatology|June 16, 2018
Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapyBéla Hunyady, Margit Abonyi, Zsuzsanna Gerlei, et al.
Pageof 9